MedPath

Eli Lilly and Co

🇺🇸United States
Ownership
-
Employees
43K
Market Cap
$859.4B
Website
Introduction

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Study the Safety and Effectiveness of Tadalafil on High Blood Pressure in the Blood Vessel Going From the Heart to the Lungs

Phase 3
Completed
Conditions
Hypertension, Pulmonary
Interventions
First Posted Date
2007-10-25
Last Posted Date
2013-04-09
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
357
Registration Number
NCT00549302
Locations
🇬🇧

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London, United Kingdom

A Study for Type 2 Diabetic Patients

Phase 4
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Drug: Insulin lispro low mixture
Drug: Insulin glargine
Drug: Insulin lispro
First Posted Date
2007-10-24
Last Posted Date
2010-09-15
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
426
Registration Number
NCT00548808
Locations
🇲🇽

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Monterrey, Mexico

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Phase 3
Completed
Conditions
Impotence
Interventions
Drug: placebo
Drug: tadalafil
First Posted Date
2007-10-22
Last Posted Date
2007-10-22
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
367
Registration Number
NCT00547573
Locations
🇨🇳

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak to your personal physician., Beijing, China

To Determine Effect and Safety of Tadalafil Taken by Men of Different Races and With Different Diseases When Needed for Erections

Phase 3
Completed
Conditions
Impotence
Interventions
First Posted Date
2007-10-22
Last Posted Date
2007-10-22
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
1933
Registration Number
NCT00547417
Locations
🇺🇸

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas, Texas, United States

Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems

Phase 2
Completed
Conditions
Prostatic Hyperplasia
Prostate
Interventions
Drug: placebo
Drug: tadalafil
First Posted Date
2007-10-22
Last Posted Date
2007-10-22
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
275
Registration Number
NCT00547625
Locations
🇺🇸

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Chicago, Illinois, United States

Study For Which Treatment, Tadalafil or Sildenafil, is Preferred For Problems Getting or Maintaining an Erection

Phase 4
Completed
Conditions
Impotence
Interventions
First Posted Date
2007-10-22
Last Posted Date
2007-10-22
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
386
Registration Number
NCT00547092
Locations
🇬🇧

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon- Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Plymouth, United Kingdom

Determine If the Stress That Comes With Not Developing an Erection Affects Tadalafil Effects

Phase 4
Completed
Conditions
Impotence
Interventions
First Posted Date
2007-10-22
Last Posted Date
2007-10-22
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
659
Registration Number
NCT00547599
Locations
🇸🇪

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Uppsala, Sweden

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

Phase 3
Completed
Conditions
Impotence
Interventions
Drug: tadalafil
Drug: placebo
First Posted Date
2007-10-22
Last Posted Date
2007-10-22
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
298
Registration Number
NCT00547183
Locations
🇩🇪

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Genthin, Germany

To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking

Phase 3
Completed
Conditions
Impotence
Interventions
Drug: placebo
Drug: tadalafil
First Posted Date
2007-10-22
Last Posted Date
2007-10-22
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
485
Registration Number
NCT00547508
Locations
🇺🇸

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Knoxville, Tennessee, United States

Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations

Phase 3
Completed
Conditions
Impotence
Interventions
First Posted Date
2007-10-22
Last Posted Date
2007-10-22
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
2760
Registration Number
NCT00547287
Locations
🇧🇷

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath